Takara Bio Inc. (JP:4974)
:4974
Total Valuation
Takara Bio Inc. has a market cap or net worth of ¥137.03B. The enterprise value is ¥127.32B.
Market Cap¥137.03B
Enterprise Value¥127.32B
Share Statistics
Takara Bio Inc. has 120,415,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding120,415,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Takara Bio Inc.’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 1.02%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)1.02%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee24.50M
Profits Per Employee566.92K
Employee Count1,838
Asset Turnover0.35
Inventory Turnover1.53
Valuation Ratios
The current PE Ratio of Takara Bio Inc. is ―. Takara Bio Inc.’s PEG ratio is -3.23.
PE Ratio―
PS Ratio2.21
PB Ratio0.86
Price to Fair Value0.86
Price to FCF-24.76
Price to Operating Cash Flow32.43
PEG Ratio-3.23
Income Statement
In the last 12 months, Takara Bio Inc. had revenue of 45.04B and earned 1.04B in profits. Earnings per share was 8.65.
Revenue45.04B
Gross Profit26.07B
Operating Income2.26B
Pretax Income2.00B
Net Income1.04B
EBITDA6.50B
Earnings Per Share (EPS)8.65
Cash Flow
In the last 12 months, operating cash flow was 4.23B and capital expenditures -12.61B, giving a free cash flow of -8.38B billion.
Operating Cash Flow4.23B
Free Cash Flow-8.38B
Free Cash Flow per Share-69.63
Dividends & Yields
Takara Bio Inc. pays an annual dividend of ¥17, resulting in a dividend yield of 2.18%
Dividend Per Share¥17
Dividend Yield2.18%
Payout Ratio-32.07%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.65
52-Week Price Change57.18%
50-Day Moving Average1.03K
200-Day Moving Average907.50
Relative Strength Index (RSI)68.83
Average Volume (3m)357.12K
Important Dates
Takara Bio Inc. upcoming earnings date is May 13, 2026, TBA (Confirmed).
Last Earnings DateFeb 13, 2026
Next Earnings DateMay 13, 2026
Ex-Dividend Date―
Financial Position
Takara Bio Inc. as a current ratio of 8.09, with Debt / Equity ratio of 9.90%
Current Ratio8.09
Quick Ratio6.34
Debt to Market Cap0.00
Net Debt to EBITDA-4.38
Interest Coverage Ratio113.15
Taxes
In the past 12 months, Takara Bio Inc. has paid 910.00M in taxes.
Income Tax910.00M
Effective Tax Rate0.46
Enterprise Valuation
Takara Bio Inc. EV to EBITDA ratio is 10.96, with an EV/FCF ratio of -17.69.
EV to Sales1.58
EV to EBITDA10.96
EV to Free Cash Flow-17.69
EV to Operating Cash Flow12.19
Balance Sheet
Takara Bio Inc. has ¥19.83B in cash and marketable securities with ¥10.00B in debt, giving a net cash position of ¥9.83B billion.
Cash & Marketable Securities¥19.83B
Total Debt¥10.00B
Net Cash¥9.83B
Net Cash Per Share¥81.65
Tangible Book Value Per Share¥895.90
Margins
Gross margin is 53.99%, with operating margin of 5.02%, and net profit margin of 2.31%.
Gross Margin53.99%
Operating Margin5.02%
Pretax Margin4.43%
Net Profit Margin2.31%
EBITDA Margin14.44%
EBIT Margin4.49%
Analyst Forecast
The average price target for Takara Bio Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-0.16%
EPS Growth Forecast-802.20%